Court of Appeal under presiding judge Klaus Grabinski overturned the PI. According to the court, it is likely that the patent-in-suitEP 4 108 782will be declared invalid in the main proceedings. This
In its first judgment, the UPC local division Lisbon has proven it is a force to be reckoned with. The judges dismissed Ericsson's application for a PI against AsusTek, but also commented on the
another case is still pending. Abbott aims to prevent the distribution of Sinocare’s GlucoMen iCan CGM system in Europe and filed two PI applications with the Dutch local division in June 2025. The
Celltrion will not face a PI from the Unified Patent Court against its biosimilar of Novartis' asthma drug Xolair. Today, Düsseldorf local division dismissed the PI application by Novartis and
Both the local and central divisions in Milan have rejected Insulet's PI applications due to doubts about the validity of the patent-in-suit. This is a setback in the company's fight over insulin
The Delhi Commercial Court issued a significant ruling in favour of Monster Energy Company in its ongoing trademark infringement case against Shree Parvati Fitness Hub Private Limited. The court grant...
For now, Formycon cannot launch its biosimilar of the macular degeneration treatment Eylea in various European markets. Munich Regional Court yesterday granted Regeneron and Bayer a preliminary injunc...
L-shaped metal member attached to the edge of this plate. PI already enforced The patent was granted in April 2025, but shortly afterwards Washtower accused Bega of infringing the patent with some of its
Yesterday, the UPC local division The Hague is hearing two PI claims by Abbott concerning a glucose-monitoring device from Sinocare and Menarini. Taylor Wessing, August Debouzy and Bird & Bird are